Education
About Us
Working with TipRanks
Follow Us
EDAP TMS S.A. (EDAP)
:EDAP
Earnings Data
Report Date
Aug 20, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.18Last Year’s EPS
-0.16Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 15, 2025
|% Change Since: -20.83%
|Next Earnings Date:Aug 20, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements such as record system placements, regulatory approvals, and positive clinical trial results. However, these were tempered by financial challenges, including a decline in overall revenue and increased net losses. Additionally, there were operational challenges related to insurance approvals. The sentiment is mixed with promising strategic developments yet notable financial setbacks.Company Guidance
In the first quarter of 2025, EDAP TMS reported significant achievements in their HIFU business, with a record placement of nine Focal One systems, contributing to a 6.8% increase in HIFU revenue to €6.2 million compared to the first quarter of 2024. However, total worldwide revenue declined by 9.1% to €13.6 million due to strategic shifts away from non-core segments. Operating expenses rose to €11.7 million, leading to a net loss of €7.1 million, or €0.19 per share. The company maintained its 2025 revenue guidance, expecting HIFU revenue growth between 16% and 25%, while non-core businesses are projected to decline by 20% to 25%. Notable developments included the launch of the new Focal One i Robotic HIFU System and the landmark remote transatlantic Focal One procedure, emphasizing EDAP’s commitment to expanding their technological leadership and market presence in focal therapy.Record Number of Focal One Placements
Nine Focal One systems were placed in Q1 2025, a record number for any prior first quarter period.
CE Mark Approval for New Indication
Focal One received CE Mark approval for treating posterior deep infiltrating endometriosis.
Launch of Focal One i Robotic HIFU System
The new Focal One i System was launched at the 2025 AUA Meeting, featuring AI and remote procedure capabilities.
Positive Clinical Trial Results
The FARP Randomized Controlled Trial showed that focal ablation is non-inferior to radical prostatectomy.
World's First Remote Transatlantic Procedure
A remote procedure was conducted between Cleveland Clinic Ohio and Cleveland Clinic Abu Dhabi using Focal One.
EDAP Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
EDAP Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 15, 2025 | $2.16 | $1.76 | -18.52% |
Mar 27, 2025 | $2.05 | $2.22 | +8.29% |
Nov 07, 2024 | $2.84 | $2.73 | -3.87% |
Aug 28, 2024 | $2.87 | $2.99 | +4.18% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does EDAP TMS S.A. (EDAP) report earnings?
EDAP TMS S.A. (EDAP) is schdueled to report earning on Aug 20, 2025, TBA Not Confirmed.
What is EDAP TMS S.A. (EDAP) earnings time?
EDAP TMS S.A. (EDAP) earnings time is at Aug 20, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EDAP EPS forecast?
EDAP EPS forecast for the fiscal quarter 2025 (Q2) is -0.18.